Health&Wellness Magazine January 2015 | Page 39

& For advertising information visit www.samplerpublications.com or call 859.225.4466 | January 2015 Approved Obesity Drugs By Angela S. Hoover, Staff Writer There is a difference between being overweight and being obese. An individual is considered obese when weight is 20 to 25 percent or more over the maximum desirable for their height. When an adult is more than 100 pounds overweight they are considered morbidly obese. Anti-obesity medication aims to reduce or control weight by altering weight regulation, altering appetite, or by altering the absorption of calories in obese and morbidly obese people. Anti-obesity drugs are used when diet and exercise are not enough but the individual does not want to undergo weight loss surgery. Drugs that work on suppressing the appetite are catecholamines and their derivatives (phentermine and other amphetamine-based drugs) and anorectics. Most anorectic drugs are also stimulants, like Dexedrine and digoxin. Antidepressants and mood stabilizers (bupropion and topiramate) are also sometimes used for appetite suppression. In the future, drugs that block the cannabinoid receptors may be a future strategy. Other drugs work on increasing the body’s metabolism. And other drugs interfere with the body’s ability to absorb specific nutrients in food, such as fats or carbohydrates. Additionally, over the counter fiber supplements glucomannan and guar gum have been used to inhibit the digestion and lowering caloric absorption. Currently, only one anti-obesity medication – orlistat (Alli, Xenical) – is approved by the FDA for long term use in the United States. For other drugs, certain weight loss benchmarks are set – usually 12 weeks. After 12 weeks, or if these benchmarks are not met within this time, then the medication should be stopped. Due to potential side effects, anti-obesity drugs are only prescribed for obesity when it is believed the benefits outweigh these risks. Some of these drugs can have severe and even lethal side effects. Some are also habit forming. Stimulants can cause high blood pressure, faster heart rate, palpitations and closed-angle glau- coma, drug addiction, restlessness, agitation and insomnia. One of the problems with anti-obesity drugs is that we do not fully understand the neural basis of appetite and how to modulate it. The body uses many chemicals and hormones to protect its stores of fat but we do not know how to circumvent this bodily process. This is why anti-obesity drugs are not practical for long-term use. Following are some of the most commonly prescribed anti-obesity medications. All of these have numerous side effects so anyone considering taking these drugs should seriously weigh the risks and benefits and talk in depth with their doctor. Acomplia Generically known as rimonabant, Acomplia works via a specific blockade of the endocannabinoid system. It has been approved in Europe for the treatment of obesity but has not yet been approved in the United States and Canada due to safety concerns. Acarbose This drug partially blocks absorption of carbohydrates in the small intestine and produces similar side effects as Xenical (orlistat). 39 Alli / Xenical Also known as orlistat, Xenical is the only anti-obesity drug approved by the FDA for long term use. It reduces intestinal fat absorption by inhibiting pancreatic lipase. As a result of it blocking the absorption of dietary fats, oily spotting of )